Open AccessAbstract 3116: Developing engineered and primary cancer cell lines for oncology drug development
Author(s) -
Hao Feng,
Wenna Zhang,
Hao Peng,
Feng He,
Zhaoshuai Bai,
Changpeng Liu,
Wang Guoqian,
Juan Xu,
Yang Qu,
Jinying Ning
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-3116
Subject(s) - cancer , t790m , erlotinib , cancer research , cell culture , colorectal cancer , egfr inhibitors , microsatellite instability , mutation , drug development , drug discovery , medicine , biology , oncology , drug , bioinformatics , pharmacology , genetics , kras , epidermal growth factor receptor , gene , allele , microsatellite